Related Experiment Video
Updated: Sep 26, 2025

08:14
Lentiviral CRISPR/Cas9-Mediated Genome Editing for the Study of Hematopoietic Cells in Disease Models
Published on: October 3, 2019
12.4K
Gaucher Disease for Hematologists
Gül Nihal Özdemir1, Eren Gündüz2
1İstinye University Faculty of Medicine, Department of Pediatric Hematology Oncology, İstanbul, Turkey
Summary
Gaucher disease (GD) is a rare genetic disorder. Early diagnosis and treatment are crucial for managing symptoms like enlarged spleen, anemia, and low platelets, especially for hematologists.
Area of Science:
- Medical Genetics
- Hematology
- Lysosomal Storage Diseases
Background:
- Gaucher disease (GD) is a rare, inherited lysosomal storage disorder caused by glucocerebrosidase deficiency.
- Common clinical signs include splenomegaly, anemia, and thrombocytopenia, often leading to initial hematologist referral.
- The Turkish Society of Hematology aims to improve rare disease awareness among hematologists.
Purpose of the Study:
- To provide hematologists with a comprehensive overview of Gaucher disease.
- To enhance understanding of GD's clinical features, pathophysiology, and treatment.
- To support the Turkish Society of Hematology's rare disease education initiatives.
Main Methods:
- Literature review of Gaucher disease.
- Synthesis of information on clinical presentation, underlying mechanisms, and therapeutic strategies.
- Focus on relevance for hematological practice.
Main Results:
- GD presents with characteristic hematological abnormalities.
- Understanding pathophysiology aids in recognizing and managing the disease.
- Various treatment options are available to mitigate complications.
Conclusions:
- Hematologists play a key role in the early diagnosis and management of Gaucher disease.
- Increased awareness and education are vital for improving patient outcomes.
- This review serves as a resource for clinicians managing rare hematological conditions.
Related Concept Videos
Bone Marrow Sampling and Transplants
523
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
523
Hematopoiesis
5.8K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.8K
Lysosomal Hydrolases
3.9K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.9K
Role of Hematopoietic Growth Factors
1.8K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.8K
Overview of Hematopoiesis
5.1K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
5.1K
Disorders of Erythrocytes
1.3K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.3K

